Last reviewed · How we verify
NCT04541758
Comparing the Efficacy of Conservative Treatment With Minimally Invasive Surgery in the Treatment of Rib Fractures
NA trial testing surgical treatment in Chest Trauma in 238 participants. Status unknown.
10 June 2023
Quick facts
| Lead sponsor | Shanghai 6th People's Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 238 |
| Start date | 1 March 2021 |
| Primary completion | 10 June 2023 |
| Estimated completion | 30 June 2024 |
Drugs / interventions tested
- surgical treatment
- Conservative treatment — full drug profile →
Conditions studied
- Chest Trauma — all drugs for Chest Trauma →
- Rib Fractures — all drugs for Rib Fractures →
- Surgery--Complications — all drugs for Surgery--Complications →
Sponsor
Shanghai 6th People's Hospital
Who can join
Adults 18 to 70, any sex, with Chest Trauma or Rib Fractures. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Open, randomized, parallel controlled prospective clinical study design was used in this study.Subjects were patients with 2-4 displaced non-flail rib fractures.Operation group (Group 1) : minimally invasive internal fixation operation group under spontaneous breathing anesthesia.In the operation group of minimally invasive internal fixation under autonomic respiratory anesthesia, the fracture was determined preoperatively by chest CT+ three-dimensional reconstruction of the ribs, and the optimal incision location was determined. The fracture was exposed through as many small incisions as possible, and fixed with titanium plate or clon-type plate. During the operation, the autonomic respiratory anesthesia and paraviral nerve block technology was adopted.In the conservative group (group 2), routine treatment measures such as analgesia and chest strap fixed were adopted.The purpose of this study was to evaluate the safety, feasibility, and efficacy of minimally invasive and conservative treatment for rib fractures with different Numbers of displaced ends.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04541758
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of surgical treatment
Trials testing the same drug.
- NCT07402252 — Effectiveness and Safety of a Type A Dissection Total Endovascular Reconstruction System in Promoting Favorable Distal A · NA · not yet recruiting
- NCT07067515 — Effectiveness of Omega-3 Poly Unsaturated Fatty Acids on The Treatment of Gingival Hyperpigmentation · Phase 1, PHASE2 · active not recruiting
- NCT05403905 — A Cohort Study of Non-surgical Treatment and Exercise Rehabilitation in Patients With Anterior Cruciate Ligament Rupture · NA · unknown
- NCT04192825 — Analysis of Therapeutic Management Strategies for Anal Suppurations of Crohn's Disease · recruiting
- NCT04961892 — Difference of Plantar Pressure Distribution Between Surgical Treatment and Conservative Treatment for CAI · completed
Other recruiting trials for Chest Trauma
Currently open trials in the same condition.
- NCT06744959 — Thorax Trauma Severity Score in Chest Trauma: A Study in Iraq · recruiting
- NCT06734338 — Validation of the STUMBL Score for Blunt Thoracic Trauma · recruiting
- NCT06707441 — Thorax vs. Trauma Injury Severity Scores as Outcome Predictors in Chest Trauma · recruiting
- NCT06078254 — Senstivity and Specificity of Lung Ultrasound for Early Detection of ARDS in Patients With Chest Trauma · recruiting
- NCT05828030 — HFNC Compared With Facial Mask in Patients With Chest Trauma Patients · NA · recruiting
Other Shanghai 6th People's Hospital trials
Trials by the same sponsor.
- NCT07482891 — An Exploratory Study on Efficacy and Safety of Fosaprepitant and Palonosetron Hydrochloride for Injection in Preventing · Phase 4 · not yet recruiting
- NCT07414277 — CGM for Insulin-Treated T2DM During Post-Discharge Transition · NA · not yet recruiting
- NCT07359053 — MAGNATE-S: Paclitaxel Polymer Micelles Combo in Advanced Sarcoma · Phase 2 · recruiting
- NCT07288372 — The CGM-OGTT Glycemic Homeostasis Study · not yet recruiting
- NCT06936657 — Intervention Effects of Optimized Carbohydrate Diet in Patients With Type 2 Diabetes · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04541758 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shanghai 6th People's Hospital
- Last refreshed: 20 January 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04541758.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing